Axcella Health Inc.

Good morning, ladies and gentlemen, and welcome to Accela's third quarter 2022 conference call. Please be advised that today's call is being recorded and that all participants will be in a listen-only mode until the question and answer session. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star and then 1 on your touch-tone phone. To withdraw your question, please press star and then 2. Now, for opening remarks, I would like to hand the call over to Bob Crane, Chief Financial Officer at Accela.

Please go ahead, sir.

Thank you very much, Operator, and good morning, everyone. We would like to advise that certain remarks we will make on today's conference call, such as those relating to our cash runway and our ongoing clinical trials of AXA 1125, include forward-looking statements that are subject to various risks and uncertainties. These risks and uncertainties are detailed in our SEC filings, including our most recent Form 10-Q, which we plan to file later today. These filings can be accessed on our website, accelatx.com, or on the SEC website. All forward-looking statements represent our views as of today, November 1st, 2022, it should not be relied upon as representing our views as of any subsequent date. We undertake no obligation to update these forward-looking statements. With that, let me turn the call over to our President and CEO, Bill Hinshaw, to begin the discussion. Bill?